Oscar Hevia, MD

Oscar Hevia, MD

Dr. Hevia’s fascination with the facial structure – especially as it is impacted by the aging process – has inspired him to pursue a specialized career focus on Cosmetic Dermatology.

Originally from Havana, Cuba, this American-raised and American-trained bi-lingual medical specialist has a long-standing reputation for his expert facial rejuvenation services. Because of this proven expertise – based on both hands-on practice and more than two decades of exceptional clinical research – has led to the development of his ever-expanding patient base among South Florida’s, as well as South America’s, socialites and celebrities, along with thousands of Miami-area residents who expect nothing short of the best medical care. A board-certified cosmetic dermatologist, Dr. Hevia is an active member of the American Society of Dermatologic Surgery.

Dr. Hevia earned his Doctorate of Medicine in 1987 from the University of Miami School of Medicine. Following a one-year internship at Mount Sinai Medical Center, Miami Beach, he went on to complete his residency at the University of Miami School of Medicine, Department of Dermatology and Cutaneous (skin) Surgery in 1991. Since completing his formal education, Dr. Hevia has not only attended scores of post-graduate medical education programs, he has established himself as a leader in the ranks of both researchers and academic physicians, as well as treating patient in his exceptionally well-regarded private practice.

His impressive and notable medical career spans more than two decades. Upon completing his residency in 1991, Dr. Hevia joined a group practice in Tallahassee, Florida, before relocating back to Coral Gables in 1999. He continued to expand his referral-driven patient base as an associate in a large dermatology practice until 2009, when he ventured into his specialized private practice. “Going solo” as a pre-eminent cosmetic dermatologist, Dr. Hevia pursues a more personalized approach to cosmetic dermatology, one that replaces cosmetic surgery with non-surgical cosmetic procedures, while providing his patients with exceptional results. His practice has flourished as a result of his stellar reputation as an expert in refreshing, restoring and rejuvenating natural beauty among his patients.

Truly inspired to explore the full potential of cosmetic dermatology, Dr. Hevia has participated in numerous clinical trials for pharmaceutical companies; he has also performed in-depth research and conducted numerous case studies to determine the effectiveness of various skin-enhancing products, a pursuit that has led to the launch of his exclusive line of skincare products, HEVIA MD SKIN SCIENCE™, released in the fall of 2011.

The high regard he enjoys from both his patients and his peers, coupled with his years of extensive training – along with his willingness to share his vast knowledge and expertise – have put Dr. Hevia at the forefront of his specialized field of non-surgical cosmetic dermatology. He currently serves as Volunteer Associate Clinical Professor at the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine; he has also published more than twenty professional peer-reviewed papers and has conducted dozens of professional-education courses for his fellow physicians. He is a sought-after speaker, lecturer and presenter at medical symposiums and expositions for prestigious hospitals, healthcare centers, educational institutions and research foundations; he also appears regularly on television programs to share his expertise in the growing popularity of cosmetic rejuvenation.

Oscar Hevia, MD
550 Biltmore Way
Coral Gables FL 33134
United States

Important Safety Information

Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.

This product is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.

Suneva Medical HD PRP
REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK170136

Silhouette Instalift
Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website www.bellafill.com.
Toll-free call (U.S. & Canada): 844-Bellafill (844-235-5234).
Local calls: 858-550-9999. International calls: ++ 858-550-9999.